Effects of Social Distancing and Lockdown Protocols on Fatality Rates of COVID-19 in the U.S. During the First Year of the Pandemic
Keywords:COVID-19, Phase Transition, New York, Washington, Kansas, Texas, California, Florida
SARS-CoV-2, the coronavirus strain responsible for the COVID-19 pandemic, can lead to severe respiratory disease and death. Worldwide, government officials tried to protect its citizens by mandating various lockdowns and social distancing policies to curb the spread. In the United States, each state initially implemented a transition or “phasing” policy that included varying degrees of safety protocols. This allowed them to re-open gradually, the goal being to reduce transmission rates while simultaneously allowing for higher degrees of public gatherings and events. The initial lockdown was observed to help suppress the pandemic, and the states–with guidance from the CDC–were left to their own agenda on how to best re-open their economy. This strategy was seen as optimal during the early stages of the pandemic. Our study aimed to determine if there was a correlation between fatality rates and phase transitions across the states.
The states selected for this study allowed for evaluation of different management styles throughout the phase transitions. COVID-19 case rates varied across the U.S.; some states observed higher infection rates than others. Thus, six states, each from regions with different caseloads and safety protocol compliance, were selected for this study: Florida, California, New York, Washington, Kansas, and Texas. Metrics such as incidence and mortality rate of COVID-19 infection were obtained from their respective government websites, allowing fatality rates to be calculated and compared using Bayesian logistic mixed models.
There are significant outcomes when analyzing the data individually and as part of a meta-analysis. When examining the fatality rates across phases grouped by individual state, there was a downward trend with each transition except in Texas. New York was found to have the lowest median fatality rate (median [IQR]; 0.011 [0.007, 0.017]), followed by Washington (0.014 [0.011, 0.020]), Kansas (0.014 [0.009, 0.021], Texas (0.018 [0.013, 0.028]), California (0.021 [0.011, 0.037]), and Florida (0.022 [0.011, 0.034]). However, when the states’ data was pooled an overall downward trend was demonstrated, with a median fatality rate of 0.039 [0.019, 0.067] in phase 0, dropping to 0.010 [0.007, 0.013] by phase 4. A decrease in fatality rate odds by about 33.4% through each phase transition was observed when combining all the states.
Based on our results, implemented safety protocols and phase transitions were shown to assist in controlling the spread of COVID-19 as the states re-opened during the first year of the pandemic. Differences in fatality rates throughout the U.S. can likely be explained by how disciplined each state was with quarantine requirements and social distancing policies. This allowed certain states to control the infectious spread more efficiently than others, thus allowing them to progress through the phase transitions at different rates as they returned to normal. Future studies are warranted and can incorporate additional states for a more robust sample size. Further accounting for confounding variables, such as patient comorbidities and the introduction of COVID-19 vaccines at the end of 2020, would also allow insight into how fatality rates have been affected across the U.S.
- 2023-02-21 (2)
- 2022-12-31 (1)
How to Cite
Copyright (c) 2022 Valerie Hardoon, Bryant A. Pierce, Solomon C. Mbanefo, Harin N. Shah, Kanav Markan, Marika L. Forsythe
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to email@example.com
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to firstname.lastname@example.org